German and Chinese Ibuprofen price increased from August to September as both markets expected to further rise during 2025. External economic pressures, changes in consumer behavior, and enhanced demand in the pharma segment compel the growth. Demand and supply factors in the German and Chinese market dictate the Ibuprofen market. On the demand side, increased consumption and awareness of over-the-counter analgesics, particularly in pharmaceuticals and healthcare, are the decisive forces, as consumers become increasingly selective of readily available remedies for everyday distress. Supply-side forces are also important, with changes in levels of production, stock levels, and raw materials prices. China, as a leading producer and exporter of Ibuprofen, holds a vital position in the world supply chain, providing consistent exports to fulfill international demands. At the same time, Germany, as one of the leading importers, is highly reliant on Chinese supplies, making it susceptible to production or price disruption. All these examples depict the market sensitivity towards global economic movements, which can attract the prices upwards in the next couple of years.
Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility.
Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
